SKandF107647: A synthetic hematoregulatory peptide in patients with solid tumor malignancies A phase I trial

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 2, 1998, Pages 189-194

  Nemunaitis, John ^a,c   Martin, David E ^b   Willis, Deborah L ^a   Freed, Martin I ^b   Levitt, Blanche ^b   Richards, Donald A ^a   Cox, John V ^a   Kimmel, Gary T ^a   Hyman, William J ^a   Jorkasky, Diane K ^b  

^a University of South Carolina   (United States)

^b SmithKline Beecham ^*  (United States)

^c TEXAS ONCOLOGY   (United States)

Author keywords

Hematoregulatory peptide; SKandF107647

Indexed keywords

COLONY STIMULATING FACTOR; GLASPIMOD; UNCLASSIFIED DRUG; IMMUNOLOGICAL ADJUVANT; OLIGOPEPTIDE; SK&F 107647;

ADULT; AGED; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HEMATOPOIESIS; HUMAN; MALE; NAUSEA; NERVOUSNESS; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; VOMITING; MIDDLE AGED; NEOPLASM; PHASE 1 CLINICAL TRIAL;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; FEMALE; HEMATOPOIESIS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OLIGOPEPTIDES;

EID: 0032037925     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199804000-00020     Document Type: Article

References (30)

1. Vose JM, Armitage JO. Clinical applications of hematopoietic growth factors. J Clin Oncol 1995;13:1023-35.
2. Steward WP. Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 1993;342:153-7.
3. Crawford J, Ozer H, Stoller R, Johnson D, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer (r-met HuG-CSF). N Engl J Med 1991;325:164-70.
4. Nemunaitis J, Buckner CD, Dorsey KS, et al. Retrospective analysis of infectious disease in patients who received rhGM-CSF versus patients not receiving a cytokine who underwent autologous bone marrow transplant for treatment of lymphoid cancer. Am J Clin Oncol In press.
5. Gabrilove JL, Jakubowski A, Scher H, et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.
6. Nemunaitis J, Rabinowe SN, Singer JW, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991;324:1773-8.
7. Munn DH, Cheung NKV. Preclinical and clinical studies of macrophage colony-stimulating factor. Semin Oncol 1992;19:395-407.
8. Nemunaitis J, Shannon-Dorcy K, Applebaum FR, et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1993;82:1422-7.
9. Broxmeyer HE. Combination cytokine therapy or a single compound that may indirectly mimic such effects by stimulating production of multiple cytokines. Exp Hematol 1992;20:149-51.
10. Rytömaa T, Kivieniemi K. Control of granulocyte production. II. Mode of action of chalone and antichalone. Cell Tissue Kinet 1968;1:341-50.
11. Paukovits WR. Control of granulocyte production: separation and chemical identification of a specific inhibitor. Cell Tissue Kinet 1971;4:539-47.
12. Paukovits WR, Laerum OD. Isolation and synthesis of a hematoregulatory peptide. Z Naturforsch 1982;37C:1297-1300.
13. Laerum OD, Paukovits WR. Inhibitory effects of a synthetic pentapeptide on hematopoietic stem cells in vitro and in vivo. Exp Hematol 1984;12:7-17.
14. Foa P, Lu L, Broxmeyer HE. A synthetic pentapeptide candidate for the role of granulocyte chalone. In: Baserga R, Metcalf D, Foa P, et al., eds. Biological regulation of cell proliferation. Serono Symposia. Vol. 34, 1st ed. New York: Raven Press, 1986:46-52.
15. Laerum OD, Sletvold O, Bjerknes R. A synthetic hematoregulatory peptide (HP5B) inhibits human myelopoietic colony formation (CPU-GM) but not leukocyte phagocytosis in vitro. Eur J Haematol 1987;39:259-66.
16. Aardal NP, Laerum OD, Paukovits WR. Biological properties of partially purified granulocyte extract (chalone) assayed in soft agar culture. Virchows Arch 1982;38:253-61.
17. Laerum OD, Sletvolt O, Bjerknes R, et al. The dimer of hemoregulatory peptide (HP5B) stimulates mouse and human myelopoiesis in vitro. Exp Hematol 1988;16:274-80.
18. Veiby OP, Lovhaug D, Fjerdingstad H, et al. Indirect stimulation of hemopoiesis by hemo-regulatory peptide (HP5b) dimer in murine long-term bone marrow cultures. Exp Hematol 1992;20:192-5.
19. Langen P, Schunck H, Hunger B, et al. Adherent-cell-dependent stimulation of CFU-GM by nucleobases, nucleotides, their analogues, and the hematoregulatory peptide dimer. Exp Hematol 1992;20:196-200.
20. Weiss SJ, Lampert MB, Test ST. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 1983;222:625-7.
21. King AG, Talmadge JE, Badger AM, et al. Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide. HP-5. Exp Hematol 1992;20:223-8.
22. Nemunaitis J, Macrophage function activating cytokines: potential clinical application. Crit Rev Oncol Hematol 1993;14:153-71.
23. King AG, Bhatnagar P, Balcarek J. Modulation of bone marrow stromal cell production of colony stimulating activity by the synthetic peptide, SK&F 107647. Exp Hematol 1991;19:481.
24. Pelus LM, DeMarsh P, King A. In vitro and in vivo hematopoietic activity of a novel synthetic hematoregulatory peptide. J Cell Biochem 1991;16C:87-91.
25. Pelus LM, Bhatnagar P, Frey C. Stimulation of murine myelopoiesis in vitro and in vivo by the synthetic peptide SK&F 107647. Exp Hematol 1991;19:488-93.
26. Pelus LM, King AG, Broxmeyer HE, et al. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide. Exp Hematol 1994;22:239-47.
27. DeMarsh PL, Sucoloski SK, Frey CL, et al. Efficacy of the hematoregulatory peptide SK&F 107647 in experimental systemic Candida albicans infections in normal and immunosuppressed mice. Immunopharmacology 1994;27:199-206.
28. Brocks DR, Freed MI, Martin DE. Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients. Pharmacol Res 1996;13:794-7.
29. Allen GD. MODFIT A pharmacokinetics computer program. Biopharm Drug Dispos 1990;10:477-98.
30. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharmacol Res 1993;10:1093-5.